江苏华盛锂电材料股份有限公司（以下简称"公司"）为加快国际化战略布局，增强公司的境外融资能 力，进一步提高公司的资本实力和综合竞争力，根据公司总体发展战略及运营需要，公司正在筹划在境 外发行股份（H股）并在香港联合交易所有限公司（以下简称"香港联交所"）上市（以下简称"本次H股 上市"）。截至本公告披露日，公司正在与相关中介机构就本次H股发行上市的具体推进工作进行商 讨，相关细节尚未确定，本次H股发行上市不会导致公司控股股东和实际控制人发生变化。 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688353 证券简称：华盛锂电 公告编号：2026-003 江苏华盛锂电材料股份有限公司 关于筹划发行H股股票并在香港联合交易所有限公司上市的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 江苏华盛锂电材料股份有限公司董事会 2026年1月9日 根据《中华人民共和国公司法》《中华人民共和国证券法》《境内企业境外发行证券和上市公司管理试 行办法》《上海证券交易所科创板股票上市规则》及《香港联合交易所有限公司证 ...

Core Viewpoint - The trend of A-share companies "going south" to list on H-shares is gaining momentum in early 2026, driven by a combination of policy support, financing needs, and internationalization strategies [1][2][3] Group 1: Companies Going Public - Six A-share companies, including Jucheng Co., Penghui Energy, and Zhengtai Electric, have announced plans for H-share listings from January 1 to January 8, 2026 [1] - Four additional companies, including Jingwang Electronics and Yifang Bio, have submitted prospectuses to the Hong Kong Stock Exchange [1] - The trend is primarily led by technology companies, with a focus on sectors such as semiconductor design, energy storage, and smart mobility [1] Group 2: Market Dynamics - The 2026 "southbound" trend is a continuation of the 2025 A+H listing boom, with a significant increase in active listing applications in Hong Kong [2] - In 2025, 19 A-share companies listed on the Hong Kong market, raising a total of approximately 139.99 billion HKD, nearly half of the total IPO amount for the year [2] - The average time for A+H listings in 2025 was reported to be 4 to 6 months, with the fastest taking only about 3 months [2] Group 3: Strategic Motivations - A-share companies are pursuing H-share listings to raise funds for global expansion and enhance their competitive position in international markets [3][4] - Companies like Jucheng Co. and Penghui Energy emphasize that listing in Hong Kong will help them build a diversified capital operation platform and support overseas business development [3] - The need for substantial foreign currency funding for overseas production and supply chain establishment is a key driver for these companies [4] Group 4: Regulatory Environment - The favorable regulatory environment, including cooperation measures between mainland and Hong Kong regulatory bodies, has made cross-border listings more feasible [4] - The Chinese Securities Regulatory Commission has expressed support for leading mainland companies to list in Hong Kong, facilitating a quicker approval process for qualified firms [4] - The current valuation of Hong Kong stocks is perceived to be lower than that of A-shares, prompting some companies to accept lower valuations to secure international funding and prepare for stricter overseas disclosure standards [4] Group 5: Market Expectations - The IPO market in Hong Kong is expected to perform well in 2026, with projections of over 300 billion HKD in IPO scale and 150 to 200 projects [4] - The growth in the MSCI China Index's earnings is anticipated to reach 14% or higher, driven by sectors such as high-end manufacturing and companies with global expansion capabilities [4]

Group 1: Company Performance - Wens Foodstuff Group (温氏股份) expects a net profit of 5.00 billion to 5.50 billion yuan for 2025, representing a year-on-year decline of 40.73% to 46.12% [1][2] - The net profit after deducting non-recurring gains and losses is projected to be 4.80 billion to 5.30 billion yuan, down 44.64% to 49.86% compared to the previous year [1][2] - The decline in performance is attributed to a significant drop in the sales price of live pigs, which averaged 13.71 yuan per kilogram, a decrease of 17.95% year-on-year, and a reduction in profits from the pig farming business [1][2] Group 2: IPO and Financing Activities - Gude Electric Materials (固德电材) has received approval for its IPO on the ChiNext board, aiming to raise 1.176 billion yuan for the production of new energy vehicle components and other projects [3] - Tongcheng New Materials (彤程新材) is planning to issue H-shares and apply for listing on the Hong Kong Stock Exchange, although details remain uncertain [4] - Huasheng Lithium Battery (华盛锂电) is also preparing to issue H-shares for listing in Hong Kong to enhance its international strategy and financing capabilities [5] - Quanxin Co., Ltd. (全信股份) plans to issue convertible bonds to raise no more than 312 million yuan for various projects and working capital [6] Group 3: Mergers and Acquisitions - Beifang Changlong (北方长龙) intends to acquire 51% of Shunyi Technology (顺义科技) through a cash transaction, which will make Shunyi a subsidiary of Beifang Changlong [8] Group 4: Regulatory Compliance - Yingjixin Technology (英集芯) received a regulatory warning from the Shanghai Stock Exchange for inaccurate and incomplete information disclosure regarding its IPA1299 chip product [9] - Yihuilong Biotechnology (亚辉龙) was also warned by the Shanghai Stock Exchange for inconsistent statements in its announcements and insufficient risk disclosures [10] Group 5: Company Announcements - Jinli Permanent Magnet (金力永磁) forecasts a net profit of 660 million to 760 million yuan for 2025, an increase of 127% to 161% year-on-year, driven by increased R&D investment and market expansion [11] - Yinqu Technology (盈趣科技) anticipates a net profit of 540 million to 660 million yuan for 2025, reflecting a growth of 114.69% to 162.40% year-on-year, supported by revenue growth and increased R&D efforts [13] - Yongxi Electronics (甬矽电子) expects a net profit of 75 million to 100 million yuan for 2025, representing a year-on-year increase of 13.08% to 50.77% due to growth in the semiconductor industry [15] - China Merchants Energy Shipping (招商轮船) projects a net profit of 6.0 billion to 6.6 billion yuan for 2025, an increase of 17% to 29% year-on-year, benefiting from market recovery and non-recurring gains [16]

Core Viewpoint - Company plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance international strategy and financing capabilities [1] Group 1: Company Overview - Company, Huasheng Lithium Battery, is a leading supplier of electrolyte additives such as Vinylene Carbonate (VC) and Fluoroethylene Carbonate (FEC) [1][2] - The company has established partnerships with well-known lithium battery manufacturers including Mitsubishi Chemical, BYD, and Tianqi Materials, covering markets in Asia, Europe, and America [2] Group 2: Production Capacity and Market Demand - The company has production bases in Zhangjiagang and a wholly-owned subsidiary, Taixing Huasheng, with a total production capacity of 14,000 tons per year for VC and FEC products [2] - Recent demand growth in the downstream power and energy storage markets has led to significant price increases for VC and FEC products [2] - The company maintains a high capacity utilization rate, with product pricing dynamically adjusted based on supply-demand relationships and raw material costs [2] Group 3: Future Projects and Innovations - To meet market demand, the company plans to invest 950 million yuan in a new project to produce 60,000 tons of Vinylene Carbonate, with the first phase targeting 30,000 tons [2] - The company is also engaged in the solid-state battery sector, having completed laboratory trials for various solid-state/half-solid-state battery materials, although these have not yet reached commercialization [3]

Group 1 - Jinli Permanent Magnet expects a net profit of 660 million to 760 million yuan for 2025, representing a year-on-year growth of 127% to 161% [1] - Wens Foodstuffs anticipates a net profit of 5 billion to 5.5 billion yuan for 2025, a decrease of 40.73% to 46.12% compared to the previous year [2] - New Open Source plans to repurchase shares worth 40 million to 50 million yuan, with a maximum repurchase price of 25.77 yuan per share [3] Group 2 - Fosun Pharma's subsidiary has had a drug registration application accepted for a new drug targeting ALK-positive non-small cell lung cancer [4] - Leike Film reported a net profit of -86 million yuan for the first three quarters of 2025, indicating a potential annual loss [5] - Crown Stone Technology's application for a specific issuance of A-shares has been accepted by the Shanghai Stock Exchange [6] Group 3 - Dongxin Technology has completed the business registration change for its subsidiary, Lishuan Technology, and has invested 211 million yuan in it [7] - Tianci Materials has increased its commodity futures hedging business limit from 150 million to 300 million yuan [8] - Gaode Infrared's actual controller has reduced his shareholding by 0.54%, bringing his stake down to 62.95% [9] Group 4 - Tianyong Intelligent expects a net profit of 10 million to 15 million yuan for 2025, marking a turnaround from losses [10][11] - China Merchants Energy anticipates a net profit of 6 billion to 6.6 billion yuan for 2025, an increase of 17% to 29% year-on-year [18] - Guangdong Electric Power A's Huizhou Power Plant's Unit 5 has been put into commercial operation, with an investment of 8.05 billion yuan [19] Group 5 - Jianghuai Automobile reported a 42.24% year-on-year increase in sales volume for December 2025 [25] - China Pharmaceutical's subsidiary has received a drug registration certificate for a new medication [26] - TianNeng Co. plans to use up to 12 billion yuan of its own funds for entrusted wealth management [27] Group 6 - Luoyang Huizhong reported a 10.55% month-on-month decrease in sales revenue from live pigs for December 2025 [28] - Baolidi expects a net profit of 145 million to 152 million yuan for 2025, a year-on-year increase of 27.17% to 33.30% [30] - Changchun High-tech's subsidiary has had a melatonin granule registration application accepted [31] Group 7 - Zhongmin Energy reported a 4.46% year-on-year decrease in cumulative on-grid electricity for 2025 [32] - Huaxin Electronics reported a 7.79% year-on-year decrease in consolidated operating revenue for December 2025 [35] - Xiamen Airport reported a 2.79% year-on-year increase in passenger throughput for December 2025 [36] Group 8 - Baiyun Airport reported a 12.27% year-on-year increase in passenger throughput for December 2025 [37] - Pulaike has received a new veterinary drug registration certificate for a chewable tablet [38] - Yunnan Energy Holdings' subsidiary has reduced its stake to 84% after a capital increase [39] Group 9 - Gansu Energy Chemical's new thermal power project has successfully completed trial operation [41] - Zhenghong Technology reported a significant decrease in sales revenue from live pigs for December 2025 [42] - Huasheng Lithium Battery is planning to issue H-shares for listing on the Hong Kong Stock Exchange [43] Group 10 - Jincheng Mining has signed a mining production contract with an estimated total price of approximately 510 million yuan [44] - Microchip Biotech has received approval for clinical trials of a new drug for pancreatic cancer [45] - Yahon Pharmaceutical has completed the first patient enrollment for a Phase I clinical trial of its drug [46]

Group 1 - The company, Huasheng Lithium, announced plans to issue H-shares and list on the Hong Kong Stock Exchange [2][3] - The company is currently in discussions with relevant intermediaries regarding the specifics of the H-share issuance and listing [2] - The H-share listing will not change the company's controlling shareholder or actual controller, but will require approval from the board, shareholders, and regulatory bodies [3] Group 2 - The H-share listing plan aims to accelerate the company's international strategic layout and enhance its overseas financing capabilities [3] - The initiative is part of the company's overall development strategy and operational needs to improve capital strength and competitive edge [3]

Core Viewpoint - Jiangsu Huasheng Lithium Battery Materials Co., Ltd. is planning to issue H-shares and list on the Hong Kong Stock Exchange to accelerate its international strategy and enhance its overseas financing capabilities [1] Group 1: Company Strategy - The company aims to strengthen its capital strength and overall competitiveness through the issuance of H-shares [1] - Discussions with relevant intermediaries regarding the specifics of the H-share issuance and listing are currently underway [1] Group 2: Regulatory and Approval Process - The H-share issuance will not result in changes to the company's controlling shareholder or actual controller [1] - The specific plan for the H-share listing will require approval from the company's board of directors and shareholders, as well as regulatory approval from the China Securities Regulatory Commission, Hong Kong Stock Exchange, and the Securities and Futures Commission of Hong Kong [1]

本次 H 股上市能否通过审议、备案和审核程序并最终实施具有重大不确定 性。后续，公司将依据相关法律法规的规定，根据本次 H 股上市的后续进展情 况及时审批并履行信息披露义务。本次发行上市尚存在较大不确定性，敬请广大 投资者关注后续公告，理性投资并注意投资风险。 1 证券代码：688353 证券简称：华盛锂电 公告编号：2026-003 特此公告。 江苏华盛锂电材料股份有限公司 关于筹划发行 H 股股票并在香港联合交易所有限公司 上市的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 江苏华盛锂电材料股份有限公司（以下简称"公司"）为加快国际化战略布 局，增强公司的境外融资能力，进一步提高公司的资本实力和综合竞争力，根据 公司总体发展战略及运营需要，公司正在筹划在境外发行股份（H 股）并在香港 联合交易所有限公司（以下简称"香港联交所"）上市（以下简称"本次 H 股上 市"）。截至本公告披露日，公司正在与相关中介机构就本次 H 股发行上市的具 体推进工作进行商讨，相关细节尚未确定，本次 H 股发行上市不会导致公司控 ...

华盛锂电(688353.SH)发布公告，为加快国际化战略布局，增强公司的境外融资能力，进一步提高公司 的资本实力和综合竞争力，根据公司总体发展战略及运营需要，公司正在筹划在境外发行股份(H股)并 在香港联合交易所有限公司(简称"香港联交所")上市。 ...

Core Viewpoint - The company is planning to issue shares (H-shares) and list on the Hong Kong Stock Exchange to accelerate its international strategy and enhance its overseas financing capabilities [1] Group 1: Company Strategy - The company aims to strengthen its capital strength and overall competitiveness through the planned H-share issuance [1] - Discussions with relevant intermediaries regarding the specific progress of the H-share issuance and listing are currently ongoing, with details yet to be finalized [1] Group 2: Ownership Structure - The planned H-share issuance and listing will not result in any changes to the company's controlling shareholder or actual controller [1]